It has been suggested that BED-associated rumination and intrusive thoughts may benefit from the use of psychedelic medicine.75 In addition, psilocybin improves impulsivity and mood state, which may be therapeutic to individuals with BED by limiting emotional eating, a key contributor to bingeing.76 As a 5-HT agonist, psilocybin may also exhibit therapeutic benefit to abnormal neurotransmitter signaling in BED, although this has yet to be experimentally validated. The gene discussed is HTR5A; the disease is X-linked cone dysfunction syndrome with myopia.